Vish Sridharan, MD

Vish Sridharan is an Associate Portfolio Manager and Research Analyst on the Health Care Sector Research Team at Janus Henderson Investors. He joined the firm and team as a research analyst focused on biotechnology companies in 2022 and added associate portfolio manager duties to his role in 2025. Before joining the firm, Vish was in practice at Massachusetts General Hospital, where he also consulted for investment management firms on science-intensive or clinical opportunities. Additionally, Vish has worked with numerous biotechnology, capital management and pharmaceutical firms while earning multiple professional degrees and performing research at the Dana Farber Cancer Center and Brigham and Women’s Hospital.

Vish received a Bachelor of Science degree (Hons) in chemistry from University of North Carolina, graduating Phi Beta Kappa and an MBA from Harvard Business School. He also earned a doctor of medicine degree from the Harvard-MIT Program in Health Science and Technology, graduating with honours. He is board-certified in Internal Medicine and continues to see hospitalised patients in an ad-hoc capacity. He has 6 years of financial industry experience.